The Understudied Consequences of Peripheral Neuropathy after Chemotherapy
September 8, 2017
MS May Be Suppressed by Human Gut Microbes, New Research Suggests
September 11, 2017
Show all

With Opioid Crisis, A Surge In Hepatitis C

Hepatitis C infections are on the rise.

In an unrelenting opioid epidemic, hepatitis C is infecting tens of thousands of mostly young, white injection drug users, with the highest prevalence in the same Appalachian, Midwestern and New England states that are seeing the steepest overdose death rates.

Like the opioid epidemic that is driving it, the rate of new hepatitis C cases has spiked in the last five years. After declining for two decades, new hepatitis C cases shot to an estimated 34,000 in 2015, nearly triple the number in 2010, according to a recent report from the U.S. Centers for Disease Control and Prevention (CDC).

With better screening for the bloodborne disease and more treatment using costly but highly effective new drugs, hepatitis C could be eradicated, according to a new study from the National Academies of Sciences, Engineering, and Medicine.

Read full article: With Opioid Crisis, A Surge In Hepatitis C | HuffPost

Read Full Article: With Opioid Crisis, A Surge In Hepatitis C | HuffPost

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.